These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3919919)

  • 41. Low-dose radiobiology program at Canadian nuclear laboratories: past, present, and future.
    Wang Y; Bannister LA; Sebastian S; Le Y; Ismail Y; Didychuk C; Richardson RB; Flegal F; Paterson LC; Causey P; Fawaz A; Wyatt H; Priest N; Klokov D
    Int J Radiat Biol; 2019 Oct; 95(10):1361-1371. PubMed ID: 30582711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glimpses of particle radiobiology.
    Raju MR
    Strahlenther Onkol; 1990 Jan; 166(1):2-5. PubMed ID: 2154045
    [No Abstract]   [Full Text] [Related]  

  • 43. Keynote address: the scientific basis of the present and future practice of clinical radiotherapy.
    Fletcher GH
    Int J Radiat Oncol Biol Phys; 1983 Jul; 9(7):1073-82. PubMed ID: 6345488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The changing role of radiation oncology in cancer management.
    Brady LW
    Cancer; 1983 Jun; 51(12 Suppl):2506-14. PubMed ID: 6406035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evolution of practical radiobiological modelling.
    Jones B; Dale RG
    Br J Radiol; 2019 Jan; 92(1093):20180097. PubMed ID: 29557215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The importance of radiobiology to cancer therapy: current practice and future perspectives.
    Hirst DG
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):367-9. PubMed ID: 17451922
    [No Abstract]   [Full Text] [Related]  

  • 47. [Normal tissue tolerance to high LET radiotherapy].
    Morita S; Tsunemoto H
    Gan No Rinsho; 1990 Oct; 36(13):2348-52. PubMed ID: 2123504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Uneven irradiation of tumors (the problem of protecting normal tissues)].
    Aliev BM; Gus'kova AK
    Med Radiol (Mosk); 1975 Feb; 20(2):74-87. PubMed ID: 805889
    [No Abstract]   [Full Text] [Related]  

  • 49. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.
    Thames HD; Peters LJ; Withers HR; Fletcher GH
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):127-38. PubMed ID: 6833014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radiobiological analysis of the use of low-intensity irradiation doses in radiation therapy].
    Kurpeshev OK
    Med Radiol (Mosk); 1980 Aug; 25(8):68-74. PubMed ID: 6995780
    [No Abstract]   [Full Text] [Related]  

  • 51. Cure of EMT-6 tumors by X rays or neutrons: effect of mixed-fractionation schemes.
    Rasey JS; Carpenter RE; Nelson NJ; Parker RG
    Radiology; 1977 Apr; 123(1):207-12. PubMed ID: 403569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Developing aspects of radiation oncology.
    Fowler JF
    Med Phys; 1981; 8(4):427-34. PubMed ID: 6798395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relevance of experimental radiobiology to radiotherapy. Present limitations and future possibilities.
    Alper T
    Br Med Bull; 1973 Jan; 29(1):3-6. PubMed ID: 4598447
    [No Abstract]   [Full Text] [Related]  

  • 54. [Physical and dosimetric bases of therapy using densely ionized particles and fast neutrons].
    Lorenz WJ; Höver KH
    Strahlentherapie; 1974 Nov; 148(5):497-501. PubMed ID: 4216992
    [No Abstract]   [Full Text] [Related]  

  • 55. An overview of recent charged-particle radiation biology in Italy.
    Belli M
    Phys Med; 2001; 17 Suppl 1():278-82. PubMed ID: 11780619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growting points in mammalian radiobiology and their implications for radiothrapy.
    Berry RJ
    Radiol Clin North Am; 1969 Aug; 7(2):281-92. PubMed ID: 4980614
    [No Abstract]   [Full Text] [Related]  

  • 58. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some considerations of physical and biological factors in radiotherapy with high-LET radiations including heavy particles, pi mesons, and fast neutrons.
    Tobias CA; Lyman JT; Lawrence JH
    Prog At Med; 1971; 3():167-218. PubMed ID: 5004402
    [No Abstract]   [Full Text] [Related]  

  • 60. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
    Stuschke M; Budach V; Stüben G; Streffer C; Sack H
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.